financetom
Business
financetom
/
Business
/
India can seek extradition of Mehul Choksi without Red Corner Notice, says CBI
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India can seek extradition of Mehul Choksi without Red Corner Notice, says CBI
Aug 27, 2018 4:58 AM

India can seek extradition of fugitive billionaire Mehul Choksi without an Interpol Red Corner Notice as it is not a mandatory requirement for the process, the CBI has told the ministry of external affairs.

In a communication to the ministry earlier this month, the agency said the purpose of a Red Corner Notice (RCN) is to locate an absconding accused which has already been achieved in Choksi's case after confirmation from Antigua that he is their citizen, officials said.

They also said that having an RCN is of little value now as Antigua has granted him citizenship and Choksi is now an Antiguan passport holder.

The agency has communicated to the ministry that it has already written to its counterpart agency in Antigua for the provisional arrest of Choksi, who is the alleged mastermind of the over $2 billion bank fraud in the Punjab National Bank.

"The contention of Antiguan authorities that the only way the movement of Choksi could be restricted is through issue a Red Corner Notice is not legally sound as primary objective of locating the subject has already been addressed," the letter said.

The subsequent steps for a provisional arrest and an extradition will have to be taken by Antigua for which an RCN is not a "prerequisite", the officials said.

Choksi has appealed to the Interpol to not issue an RCN against him as the charges are politically motivated, they said.

He also said the conditions of jails in India are not good and staying their would violate his human rights, the officials said.

Choksi, the uncle of his alleged partner in crime Nirav Modi, also said the charges against him have been hyped by the media and he might not get a fair trial in India as courts may be influenced by news reports, they said.

The Interpol, after receiving Choksi's plea, sought the CBI's reply which the Indian agency has sent denying all allegations levelled by him.

The promoter of the Gitanjali group, Choksi, had left India in the first week of January, nearly a fortnight before the biggest banking scam was detected in the Punjab National Bank's Brady House branch.

He had taken an oath of allegiance in Antigua on January 15, 2018, thus completing his citizenship, which was granted to him in November, 2017.

First Published:Aug 27, 2018 1:58 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Optimism Over U.S. Tariff Impact Best Reflected in Canadian Dollar, Says Mitsubishi UFG
Optimism Over U.S. Tariff Impact Best Reflected in Canadian Dollar, Says Mitsubishi UFG
Mar 28, 2025
07:12 AM EDT, 03/28/2025 (MT Newswires) -- While there are signs of increased risk aversion on Friday, the overall financial market reaction to the 25% global tariff on autos and auto parts continues to be relatively muted, with most G10 currencies still stronger against the US dollar (USD) since United States President Donald Trump's announcement, said MUFG. The yen (JPY)...
EU regulator rejects Eli Lilly's Alzheimer's drug
EU regulator rejects Eli Lilly's Alzheimer's drug
Mar 28, 2025
March 28 (Reuters) - The European Union's drugs regulator on Friday rejected Eli Lilly's ( LLY ) Alzheimer's drug, saying the risk of serious brain swelling did not outweigh the treatment's small impact on slowing cognitive decline. The rejection of the drug, Kisunla, means Eisai ( ESALF ) and Biogen's Leqembi will likely pull ahead in the race to become...
Aimia Q4 Net Loss Narrows, Provides Guidance, Names New Executive Chairman
Aimia Q4 Net Loss Narrows, Provides Guidance, Names New Executive Chairman
Mar 28, 2025
07:05 AM EDT, 03/28/2025 (MT Newswires) -- Aimia ( AIMFF ) on Friday reported a narrower fourth-quarter net loss as revenue increased. Th net loss came in at $41.2 million, or $0.48 per share, compared with a loss of $59 million, or $0.69 per share. Revenue rose to $127.2 million from $100.1 million. Adjusted EBITDA swung to $17.3 million from...
US FDA declines to approve Milestone Pharma's heart rhythm nasal spray
US FDA declines to approve Milestone Pharma's heart rhythm nasal spray
Mar 28, 2025
March 28 (Reuters) - The U.S. Food and Drug Administration has declined to approve Milestone Pharmaceuticals' ( MIST ) nasal spray to treat a type of heart condition, the company said on Friday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved